• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

Recent Advances in the Study of 2-Cyclopropyl-6-methylmorpholine (CAS: 1343652-74-3) in Chemical Biology and Pharmaceutical Research

The compound 2-cyclopropyl-6-methylmorpholine (CAS: 1343652-74-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential as a drug candidate. The information presented herein is derived from peer-reviewed studies and industry reports published within the last two years, ensuring the relevance and accuracy of the data.

Recent studies have highlighted the versatility of 2-cyclopropyl-6-methylmorpholine as a key intermediate in the synthesis of novel bioactive molecules. Its morpholine core, coupled with the cyclopropyl and methyl substituents, provides a scaffold that can be readily modified to enhance pharmacological properties. For instance, researchers have successfully utilized this compound in the development of kinase inhibitors, which show promise in targeting various cancers and inflammatory diseases. The compound's ability to modulate enzyme activity has been demonstrated in vitro, with notable efficacy against specific kinase targets.

One of the most significant breakthroughs involves the application of 2-cyclopropyl-6-methylmorpholine in the design of small-molecule inhibitors for protein-protein interactions (PPIs). PPIs are notoriously challenging to target due to their large and flat interfaces, but the structural features of this compound have enabled researchers to develop potent inhibitors with high selectivity. Recent publications describe the use of computational modeling and high-throughput screening to identify optimal derivatives of 2-cyclopropyl-6-methylmorpholine, leading to the discovery of compounds with nanomolar affinity for their targets.

In addition to its role in drug discovery, 2-cyclopropyl-6-methylmorpholine has also been investigated for its potential in agrochemical applications. Studies have shown that derivatives of this compound exhibit herbicidal and fungicidal activities, making them candidates for the development of new crop protection agents. The environmental impact and safety profile of these derivatives are currently under evaluation, with preliminary results indicating favorable biodegradability and low toxicity to non-target organisms.

Despite these promising developments, challenges remain in the optimization of 2-cyclopropyl-6-methylmorpholine-based compounds. Issues such as metabolic stability, bioavailability, and off-target effects need to be addressed to fully realize their therapeutic potential. Ongoing research is focused on structural modifications and formulation strategies to overcome these limitations. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinical applications.

In conclusion, 2-cyclopropyl-6-methylmorpholine (CAS: 1343652-74-3) represents a valuable scaffold in chemical biology and pharmaceutical research. Its diverse applications, ranging from kinase inhibitors to agrochemicals, underscore its versatility and potential for innovation. Future studies will likely explore new derivatives and applications, further expanding the utility of this compound in addressing unmet medical and agricultural needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)